Simple Serum Pancreatic Ductal Adenocarcinoma (PDAC) Protein Biomarkers—Is There Anything in Sight?
A poor PDAC prognosis is due to a lack of effective treatment and late diagnosis. The early detection of PDAC could significantly decrease mortality and save lives. Idealbiomarkers for PDAC should be cost-effective, detectable in easily accessible biological material, and present in sufficient conce...
Guardado en:
Autores principales: | Monika Kapszewicz, Ewa Małecka-Wojciesko |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8e26b0509e3a4e1394445cb12f6e1682 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma
por: Dong-jin Wu, et al.
Publicado: (2018) -
CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma
por: Cai,Yi, et al.
Publicado: (2018) -
Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma
por: Iranzu González-Borja, et al.
Publicado: (2021) -
Preoperative recurrence prediction in pancreatic ductal adenocarcinoma after radical resection using radiomics of diagnostic computed tomography
por: Xiawei Li, et al.
Publicado: (2022) -
Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas
por: Hongkai Zhuang, et al.
Publicado: (2021)